About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
156 genotypes with 213 annotations displayed of selected term and subterms
Searched Term: abnormal lymphatic vessel morphology
Allelic Composition
(Genetic Background)		 Annotated Term Reference
4933434E20Riktm1a(EUCOMM)Wtsi/4933434E20Riktm1a(EUCOMM)Wtsi
(C57BL/6N-4933434E20Riktm1a(EUCOMM)Wtsi/Wtsi) 		enlarged lymphatic vessel J:239583
Adamts3tm1.2Itl/Adamts3tm1.2Itl
(involves: BALB/cJ * C57BL/6NTac * SJL) 		abnormal lymphangiogenesis J:245044
absent lymphatic vessels J:245044
Angpt1tm1.1Seq/Angpt1tm1.1Seq
Angpt2tm1c(KOMP)Seq/Angpt2tm1c(KOMP)Seq
Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy/?
Tg(tetO-cre)1Jaw/0
(involves: 129 * C57BL/6NCr) 		abnormal lymphatic vessel morphology J:217296
Angpt2tm1Gdy/Angpt2tm1Gdy
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal lymphatic vessel morphology J:89618
Angptl4Gt(OST352973)Lex/Angptl4Gt(OST352973)Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		abnormal lymphatic vessel morphology J:122968
Angptl4tm1Lex/Angptl4tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		abnormal lymphatic vessel morphology J:122968
Antxr2tm1.1Jkit/Antxr2tm1.1Jkit
(involves: 129 * C57BL/6) 		lymphangiectasis J:187210
Atg16l1tm1a(EUCOMM)Wtsi/Atg16l1tm1a(EUCOMM)Wtsi
(C57BL/6N-Atg16l1tm1a(EUCOMM)Wtsi/Wtsi) 		absent connection between subcutaneous lymph vessels and lymph sac J:239583
Awat2tm1.2Golc/Y
(involves: 129 * C57BL/6 * C57BL/6J) 		abnormal lymphangiogenesis J:308387
Awat2tm1.2Golc/Awat2tm1.2Golc
(involves: 129 * C57BL/6 * C57BL/6J) 		abnormal lymphangiogenesis J:308387
B9d2tm1a(EUCOMM)Wtsi/B9d2tm1a(EUCOMM)Wtsi
(C57BL/6N-B9d2tm1a(EUCOMM)Wtsi/Wtsi) 		enlarged lymphatic vessel J:239583
Brd2em1(IMPC)Wtsi/Brd2em1(IMPC)Wtsi
(C57BL/6N-Brd2em1(IMPC)Wtsi/WtsiIeg) 		absent connection between subcutaneous lymph vessels and lymph sac J:239583
Casz1Gt(CJ0565)Wtsi/Casz1Gt(CJ0565)Wtsi
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal lymphatic vessel morphology J:242127
enlarged lymphatic vessel J:242127
Ccbe1tm1Lex/Ccbe1tm1Lex
(involves: 129S5/SvEvBrd) 		abnormal lymphangiogenesis J:186594
absent lymphatic vessels J:186594
Ccbe1tm1Mlkn/Ccbe1tm1Mlkn
(either: B6.129-Ccbe1tm1Mlkn or (involves: 129 * C57BL/6)) 		absent lymphatic vessels J:196696
Cdh5tm3(Cdh5/Ctnna1)Dvst/Cdh5tm3(Cdh5/Ctnna1)Dvst
(involves: 129 * C57BL/6) 		abnormal lymphatic vessel endothelial cell morphology J:213676
Cdh5tm3(Cdh5/Ctnna1)Dvst/Cdh5tm3(Cdh5/Ctnna1)Dvst
(B6.Cg-Cdh5tm3(Cdh5/Ctnna1)Dvst) 		abnormal lymphatic vessel endothelium morphology J:213676
abnormal lymphatic vessel morphology J:213676
Clec1btm1.1Arte/Clec1btm1.1Arte
Tg(Pf4-icre)Q3Rsko/0
(involves: C57BL/6) 		abnormal lymphatic vessel endothelial cell morphology J:181715
abnormal lymphatic vessel morphology J:181715
Clec1btm1.1Ksi/Clec1btm1.1Ksi
(involves: C57BL/6) 		abnormal lymphatic vessel morphology J:165898
Clec1btm1.2Arte/Clec1btm1.2Arte
(Not Specified) 		abnormal lymphatic vessel morphology J:181715
decreased lymphatic vessel endothelial cell number J:181715
Clec1btm1Ksi/Clec1btm1Ksi
Tg(Pf4-icre)Q3Rsko/0
(involves: C57BL/6) 		abnormal lymphatic vessel morphology J:187533
Clec1btm1Mlkn/Clec1btm1Mlkn
(involves: 129S4/SvJae * C57BL/6) 		abnormal lymphatic vessel morphology J:162815
Cmiptm1a(EUCOMM)Wtsi/Cmiptm1a(EUCOMM)Wtsi
(C57BL/6N-Cmiptm1a(EUCOMM)Wtsi/Wtsi) 		abnormal lymphatic vessel morphology J:239583
Col1a1tm1(tetO-Cyp26b1)Mfra/Col1a1+
Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6) 		abnormal lymphatic vessel morphology J:206581
Crim1em1(IMPC)Wtsi/Crim1em1(IMPC)Wtsi
(C57BL/6N-Crim1em1(IMPC)Wtsi/WtsiOrl) 		absent connection between subcutaneous lymph vessels and lymph sac J:239583
Cyp26b1tm1Hmd/Cyp26b1tm1Hmd
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal lymphatic vessel endothelial cell morphology J:206581
Cyp26b1tm1Hmd/Cyp26b1tm1Hmd
Tg(Prox1-EGFP)KY221Gsat/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/NTac) 		abnormal lymphatic vessel endothelial cell morphology J:206581
abnormal lymphatic vessel morphology J:206581
Cyp51tm1.1Bfro/Cyp51tm1.1Bfro
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal lymphatic vessel morphology J:173366
abnormal lymphatic vessel smooth muscle morphology J:173366
Del(8A4-B3)7H/+
(involves: 101/H * C3H/HeH) 		abnormal lymphatic vessel morphology J:123074
Dhx35tm1b(EUCOMM)Wtsi/Dhx35tm1b(EUCOMM)Wtsi
(C57BL/6N-Dhx35tm1b(EUCOMM)Wtsi/Wtsi) 		absent connection between subcutaneous lymph vessels and lymph sac J:239583
Dstncorn1/Dstncorn1
(A.BY-H2bc H2-T18f/SnJ) 		abnormal lymphangiogenesis J:98465
Efnb2tm5.1Kln/Efnb2tm5.1Kln
(involves: C57BL/6) 		abnormal afferent lymphatic vessel morphology J:95885
abnormal lymphatic vessel morphology J:95885
Efnb2tm5.1Kln/Efnb2tm5.1Kln
(involves: CD-1) 		abnormal lymphatic vessel morphology J:95885
Efnb2tm5.1Kln/Efnb2tm5.1Kln
Flt4tm1Ali/Flt4+
(involves: C57BL/6) 		abnormal afferent lymphatic vessel morphology J:95885
abnormal lymphatic vessel morphology J:95885
Efnb2tm6Kln/Efnb2tm6Kln
(involves: C57BL/6) 		abnormal lymphatic vessel morphology J:95885
Elk3tm1Wlyk/Elk3tm1Wlyk
(either: (involves: 129/Sv) or (involves: 129/Sv * C57BL/6)) 		lymphangiectasis J:71816
Fat1Gt(KST249)Byg/Fat1Gt(KST249)Byg
Tg(Myl1-lacZ)1Ibdml/0
(involves: 129P2/OlaHsd) 		lymphangiectasis J:199157
Flt4Chy/Flt4+
(involves: C3H) 		abnormal lymphangiogenesis J:177405
abnormal lymphatic vessel morphology J:72387
Flt4Chy/Flt4Chy
(involves: C3H) 		abnormal lymphangiogenesis J:177405
absent lymphatic vessels J:177405
Flt4tm1.1Ichi/Flt4+
Krastm1Mok/Kras+
(involves: 129S/SvEv * C57BL/6) 		lymphatic vessel hypoplasia J:159024
Flt4tm1.1Ichi/Flt4+
Krastm1Mok/Kras+
Tg(HRAS)2Jic/0
(involves: 129S/SvEv * BALB/c * C57BL/6 * DBA/2) 		lymphatic vessel hypoplasia J:159024
Flt4tm1.2Yhe/Flt4tm1.2Yhe
(involves: 129/Sv * C57BL/6J * FVB/N) 		abnormal lymphangiogenesis J:177405
absent lymphatic vessels J:177405
Flt4tm1Ali/Flt4+
Nrp2tm1Ddg/Nrp2+
(involves: C57BL/6) 		abnormal lymphangiogenesis J:156869
Flt4tm1Ali/Flt4+
Nrp2tm1Ddg/Nrp2tm1Ddg
(involves: C57BL/6) 		abnormal lymphangiogenesis J:156869
Flt4tm1Ali/Flt4+
Tmem204tm1.1Ali/Tmem204tm1.1Ali
(involves: BALB/c * C57BL/6) 		abnormal lymphatic vessel smooth muscle morphology J:159519
enlarged lymphatic vessel J:159519
Flt4tm1Ali/Flt4tm2Ali
(involves: 129S1/Sv * 129X1/SvJ * ICR) 		absent lymphatic vessels J:137909
Flt4tm2Ali/Flt4+
(involves: 129S1/Sv * 129X1/SvJ * ICR) 		abnormal lymphatic vessel morphology J:137909
Flt4tm2Ali/Flt4tm2Ali
(involves: 129S1/Sv * 129X1/SvJ * ICR) 		absent lymphatic vessels J:137909
Foxc2tm1.1Miu/Foxc2tm1.1Miu
Tg(Tek-cre)1Ywa/0
(involves: C57BL/6 * C57BL/6J * SJL) 		abnormal lymphatic vessel morphology J:316530
Foxc2tm1Miu/Foxc2+
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J) 		abnormal thoracic duct morphology J:83436
lymphangiectasis J:83436
lymphatic vessel hyperplasia J:83436
Gdf2tm1Lex/Gdf2tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		abnormal lymphatic vessel morphology J:222016
lymphangiectasis J:222016
Gja1tm1Kwi/Gja1+
Tg(KRT5-cre)5132Jlj/0
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J) 		abnormal lymphatic vessel morphology J:188626
absent lymphatic vessels J:188626
Gjb2tm3.1(Gjb1)Kwi/Gjb2+
Tg(KRT5-cre)5132Jlj/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2J * SJL) 		abnormal lymphatic vessel morphology J:188626
Gjb2tm3.2(Gjb1)Kwi/Gjb2+
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * SJL) 		abnormal lymphatic vessel morphology J:188626
absent lymphatic vessels J:188626
Gp6tm1Beni/Gp6tm1Beni
Clec1btm1.1Arte/Clec1btm1.1Arte
Tg(Pf4-icre)Q3Rsko/0
(involves: 129 * C57BL/6) 		abnormal lymphatic vessel morphology J:217963
Gt(ROSA)26Sortm1(Ntn4)Dyl/Gt(ROSA)26Sor+
Tg(KRT14-cre)1Amc/0
(involves: 129/Sv * C57BL/6 * CBA) 		abnormal lymphangiogenesis J:162807
abnormal lymphatic vessel morphology J:162807
lymphatic vessel hyperplasia J:162807
Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sor+
Nr2f2tm2.1Tsa/Nr2f2tm2.1Tsa
Prox1tm3(cre/ERT2)Gco/Prox1+
(involves: 129S1/Sv * 129S4/SvJaeSor * 129S7/SvEvBrd * C57BL/6) 		abnormal lymphatic vessel morphology J:158959
Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sor+
Tbx1tm3.1Bld/Tbx1tm6(cre)Bld
(involves: 129S4/SvJaeSor * 129S7/SvEvBrd) 		abnormal lymphatic vessel morphology J:159824
Gt(ROSA)26Sortm7(Pik3ca*,EGFP)Rsky/Gt(ROSA)26Sor+
Tg(CAG-cre/Esr1*)5Amc/0
(B6.Cg-Gt(ROSA)26Sortm7(Pik3ca*,EGFP)Rsky Tg(CAG-cre/Esr1*)5Amc) 		enlarged lymphatic vessel J:264410
Heg1tm1Mlkn/Heg1tm1Mlkn
(either: B6.129-Heg1tm1Mlkn or (involves: 129 * C57BL/6)) 		abnormal lymphatic vessel endothelium morphology J:146528
lymphangiectasis J:146528
Ighmtm1Cgn/Ighmtm1Cgn
(involves: 129S2/SvPas * C57BL/6) 		abnormal lymphatic vessel morphology J:119344
Kdrtm1.1Jamb/Kdrtm1.1Jamb
(involves: 129S1/Sv * 129X1/SvJ * ICR) 		abnormal lymphangiogenesis J:154336
lymphatic vessel hyperplasia J:154336
Kdrtm1.1Jamb/Kdrtm1.1Jamb
Tg(KRT14-cre)1Efu/0
(involves: 129S1/Sv * 129X1/SvJ * ICR) 		lymphatic vessel hyperplasia J:154336
Kdrtm1.1Jamb/Kdrtm1.1Jamb
Tg(Pax6-cre,GFP)1Pgr/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/N * ICR) 		abnormal lymphatic vessel morphology J:154336
lymphatic vessel hyperplasia J:154336
Kdrtm1Jrt/Kdr+
Tmem204tm1.1Ali/Tmem204tm1.1Ali
(involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6) 		abnormal lymphatic vessel smooth muscle morphology J:159519
enlarged lymphatic vessel J:159519
Kdrtm1Ykub/Kdrtm1Ykub
(Not Specified) 		enlarged lymphatic vessel J:217533
lymphatic vessel hyperplasia J:217533
Krastm1Mok/Kras+
Nrastm1Mok/Nras+
(involves: 129S/SvEv * C57BL/6 * DBA/2) 		abnormal lymphatic vessel morphology J:159024
Lcp2tm1Gak/Lcp2tm2Gak
Tg(Pf4-icre)Q3Rsko/0
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal lymphatic vessel morphology J:162815
Lcp2tm1Gak/Lcp2tm2Gak
Tg(VAV1-cre)1Graf/0
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal lymphatic vessel morphology J:162815
Lgals8tm1(KOMP)Vlcg/Lgals8tm1(KOMP)Vlcg
(involves: C57BL/6NTac) 		abnormal lymphangiogenesis J:235778
Lpar4tm1Sati/Y
(involves: C57BL/6) 		lymphangiectasis J:167262
Lpar4tm1Sati/Lpar4tm1Sati
(involves: C57BL/6) 		lymphangiectasis J:167262
Lyve1tm1.1(EGFP/cre)Cys/Lyve1+
Sphk1tm2Cgh/Sphk1tm2Cgh
Sphk2tm1.1Cgh/Sphk2tm1.1Cgh
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		abnormal lymphatic vessel morphology J:156826
Lyve1tm1Lhua/Lyve1tm1Lhua
(B6.129S1-Lyve1tm1Lhua) 		lymphangiectasis J:117713
Mdficem#Nlh/Mdficem#Nlh
(C57BL/6J-Mdficem#Nlh) 		abnormal lymphatic vessel morphology J:326462
Morc2aem1(IMPC)Wtsi/Morc2aem1(IMPC)Wtsi
(C57BL/6N-Morc2aem1(IMPC)Wtsi/WtsiOulu) 		absent connection between subcutaneous lymph vessels and lymph sac J:239583
Nf1tm1Fcr/Nf1tm1Fcr
(either: (involves: 129S/SvEv) or (involves: 129S/SvEv * C57BL/6J)) 		abnormal lymphatic vessel morphology J:18048
Nfat5tm1.1Itl/Nfat5tm1.1Itl
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6NTac * FVB/N) 		abnormal lymphatic vessel morphology J:201429
Nr2f2tm2.1Tsa/Nr2f2tm2.1Tsa
Rbpjtm1Hon/Rbpjtm1Hon
Tg(Tek-cre)1Ywa/0
(involves: 129S1/Sv * 129S7/SvEvBrd * C57BL/6 * SJL) 		decreased lymphatic vessel endothelial cell number J:158959
Nr2f2tm2.1Tsa/Nr2f2tm2.1Tsa
Tg(Tek-cre)1Ywa/0
(involves: 129S1/Sv * 129S7/SvEvBrd * C57BL/6 * SJL) 		decreased lymphatic vessel endothelial cell number J:158959
Nrp2tm1.2Mom/Nrp2+
Sema3ftm1.2Ddg/Sema3f+
(involves: 129P2/OlaHsd) 		abnormal lymphatic vessel endothelial cell morphology J:226501
Nrp2tm1.2Mom/Nrp2tm1.2Mom
(involves: 129P2/OlaHsd) 		abnormal lymphatic vessel endothelial cell morphology J:226501
abnormal lymphatic vessel morphology J:226501
lymphatic vessel hyperplasia J:226501
Nrp2tm1Ddg/Nrp2tm1Ddg
(involves: C57BL/6) 		abnormal lymphangiogenesis J:156869
Nus1tm1Wcsa/Nus1tm1Wcsa
Tg(Cdh5-cre/ERT2)1Rha/0
(Not Specified) 		abnormal jugular lymph sac morphology J:230506
Pdpntm1(cre)Mlkn/Pdpntm1(cre)Mlkn
(involves: 129S4/SvJae * C57BL/6) 		abnormal lymphatic vessel morphology J:162815
Pdpntm1Mcws/Pdpn+
(involves: 129S6/SvEvTac) 		abnormal lymphatic vessel morphology J:94978
lymphangiectasis J:94978
Pdpntm1Mcws/Pdpntm1Mcws
(involves: 129S6/SvEvTac) 		abnormal lymphatic vessel morphology J:94978
lymphangiectasis J:94978
Pdpntm2.1Mlkn/Pdpntm2.1Mlkn
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129 * C57BL/6) 		abnormal lymphangiogenesis J:235778
Pdzk1tm2b(EUCOMM)Wtsi/Pdzk1tm2b(EUCOMM)Wtsi
(C57BL/6N-Pdzk1tm2b(EUCOMM)Wtsi/Wtsi) 		abnormal lymphatic vessel morphology J:239583
absent connection between subcutaneous lymph vessels and lymph sac J:239583
Pik3catm1Jdo/Pik3catm1Jdo
(B6.129S7(Cg)-Pik3catm1Jdo) 		abnormal lymphangiogenesis J:122866
abnormal lymphatic vessel morphology J:122866
Plcg2al/Plcg2al
(involves: 129 * C57BL/6) 		abnormal lymphatic vessel morphology J:143529
Plcg2tm1Ichi/Plcg2tm1Ichi
(involves: 129 * C57BL/6) 		abnormal lymphatic vessel morphology J:143529
Plxna1tm1Tmj/Plxna1tm1Tmj
(involves: 129S/SvEv) 		abnormal lymphatic vessel endothelial cell morphology J:226501
abnormal lymphatic vessel morphology J:226501
Plxna2tm1Hfu/Plxna2tm1Hfu
(involves: C57BL/6NCrlj * CBA/JNCrlj) 		abnormal lymphatic vessel morphology J:226501
Polbtm1a(KOMP)Wtsi/Polbtm1a(KOMP)Wtsi
(C57BL/6N-Polbtm1a(KOMP)Wtsi/Wtsi) 		abnormal lymphatic vessel topology J:239583
Ppp1r13btm1Suda/Ppp1r13btm1Suda
(involves: 129S1/Sv * 129X1/SvJ * ICR) 		abnormal lymphatic vessel morphology J:135686
Ppp1r13btm1Suda/Ppp1r13btm1Suda
Trp53tm1Sia/Trp53tm1Sia
(involves: various) 		abnormal lymphatic vessel morphology J:135686
Prox1tm1Gco/Prox1+
(involves: 129S1/Sv * 129X1/SvJ * NMRI) 		abnormal lymphatic vessel morphology J:102652
Prox1tm1Gco/Prox1tm2Gco
Tg(Tek-cre)1Ywa/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		absent lymphatic vessels J:125507
Prox1tm1Gco/Prox1tm5(GFP/cre)Gco
(involves: 129S1/Sv * 129X1/SvJ * NMRI) 		decreased lymphatic vessel endothelial cell number J:158959
Prox1tm2Gco/Prox1+
Tg(Tek-cre)1Ywa/0
(involves: 129S1/Sv * C57BL/6 * NMRI * SJL) 		abnormal lymphatic vessel morphology J:102652
Prox1tm4.1Gco/Prox1tm4.1Gco
(involves: 129S1/Sv * C57BL/10 * CBA/Ca) 		decreased lymphatic vessel endothelial cell number J:158959
Psphtm1a(EUCOMM)Hmgu/Psphtm1a(EUCOMM)Hmgu
(C57BL/6N-Psphtm1a(EUCOMM)Hmgu/Wtsi) 		absent connection between subcutaneous lymph vessels and lymph sac J:239583
Ptger4tm1Bhk/Ptger4tm1Bhk
(involves: 129P2/OlaHsd * 129S/SvEv) 		lymphangiectasis J:44108
Pth1rtm1a(EUCOMM)Hmgu/Pth1rtm1a(EUCOMM)Hmgu
(C57BL/6N-Pth1rtm1a(EUCOMM)Hmgu/Wtsi) 		enlarged lymphatic vessel J:239583
Ptpn14Gt(RRR484)Byg/Ptpn14Gt(RRR484)Byg
(involves: 129P2/OlaHsd) 		lymphatic vessel hyperplasia J:169186
Rag1tm1Mom/Rag1tm1Mom
(involves: 129S7/SvEvBrd * C57BL/6) 		abnormal lymphatic vessel morphology J:119344
Ramp2tm1Kmca/Ramp2tm1Kmca
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal lymphatic vessel morphology J:130930
Rpgrip1ltm1a(EUCOMM)Wtsi/Rpgrip1ltm1a(EUCOMM)Wtsi
(C57BL/6N-Rpgrip1ltm1a(EUCOMM)Wtsi/Wtsi) 		absent connection between subcutaneous lymph vessels and lymph sac J:239583
Rr270em1Mgn/Rr270em1Mgn
(involves: CD-1) 		abnormal embryonic lymph sac morphology J:328045
Sema3ftm1.2Ddg/Sema3ftm1.2Ddg
(Not Specified) 		abnormal lymphatic vessel endothelial cell morphology J:226501
abnormal lymphatic vessel morphology J:226501
Sema3ftm1.2Ddg/Sema3ftm1.2Ddg
Sema3gtm1(KOMP)Vlcg/Sema3gtm1(KOMP)Vlcg
(involves: C57BL/6NTac) 		abnormal lymphatic vessel endothelial cell morphology J:226501
abnormal lymphatic vessel morphology J:226501
lymphatic vessel hyperplasia J:226501
Sema3gtm1(KOMP)Vlcg/Sema3gtm1(KOMP)Vlcg
(involves: C57BL/6NTac) 		abnormal lymphatic vessel morphology J:226501
Setd5tm1a(EUCOMM)Wtsi/Setd5+
(C57BL/6N-Setd5tm1a(EUCOMM)Wtsi/Wtsi) 		enlarged lymphatic vessel J:239583
Sh3pxd2atm1b(EUCOMM)Wtsi/Sh3pxd2atm1b(EUCOMM)Wtsi
(C57BL/6N-Sh3pxd2atm1b(EUCOMM)Wtsi/Wtsi) 		abnormal lymphatic vessel morphology J:239583
absent connection between subcutaneous lymph vessels and lymph sac J:239583
Smg9tm1b(EUCOMM)Wtsi/Smg9tm1b(EUCOMM)Wtsi
(C57BL/6N-Smg9tm1b(EUCOMM)Wtsi/Wtsi) 		absent connection between subcutaneous lymph vessels and lymph sac J:239583
Sox18Ra-Op/Sox18Ra-Op
(B6D2-Sox18Ra-Op/J) 		abnormal lymphatic vessel morphology J:143564
Sox18tm1Koop/Sox18tm1Koop
(B6.129-Sox18tm1Koop) 		abnormal lymphatic vessel morphology J:143564
Svep1tm1a(EUCOMM)Hmgu/Svep1tm1a(EUCOMM)Hmgu
(involves: C57BL/6N) 		abnormal lymphangiogenesis J:244466
abnormal lymphatic vessel morphology J:244466
Syktm1.1(cre)Fkfr/Syktm1.1(cre)Fkfr
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sortm1(EYFP)Cos
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal lymphangiogenesis J:159112
Syktm1.1Nns/Syktm1.1Nns
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: C57BL/10 * CBA/Ca) 		abnormal lymphatic vessel morphology J:181715
Syktm1.1Nns/Syktm1.1Nns
Tg(Pf4-icre)Q3Rsko/0
(involves: C57BL/6) 		abnormal lymphatic vessel endothelial cell morphology J:181715
abnormal lymphatic vessel morphology J:181715
Syktm1.1Nns/Syktm1.1Nns
Tg(Tie1-cre)9Ref/0
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/10 * CBA/Ca) 		abnormal lymphatic vessel morphology J:181715
Syktm1Paw/Syktm1Paw
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal lymphangiogenesis J:159112
abnormal lymphatic vessel endothelium morphology J:159112
abnormal lymphatic vessel morphology J:159112
enlarged lymphatic vessel J:159112
lymphatic vessel hyperplasia J:159112
Syktm1Tyb/Syktm1Tyb
(involves: 129S2/SvPas * C57BL/6J) 		abnormal lymphatic vessel morphology J:181715
decreased lymphatic vessel endothelial cell number J:181715
Tbx1tm1Bld/Tbx1tm1Bld
(involves: 129S7/SvEvBrd) 		abnormal lymphangiogenesis J:159824
abnormal lymphatic vessel morphology J:159824
lymphangiectasis J:159824
Tbx1tm1Bld/Tbx1tm3Bld
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S7/SvEvBrd * C57BL/6 * CBA) 		abnormal lymphangiogenesis J:159824
abnormal lymphatic vessel morphology J:159824
Tbx1tm1Bld/Tbx1tm3Bld
Tg(Tek-cre)1Ywa/0
(involves: 129S7/SvEvBrd * C57BL/6 * SJL) 		abnormal lymphangiogenesis J:159824
abnormal lymphatic vessel morphology J:159824
Tent5ctm1b(KOMP)Wtsi/Tent5ctm1b(KOMP)Wtsi
(C57BL/6N-Tent5ctm1b(KOMP)Wtsi/Wtsi) 		absent connection between subcutaneous lymph vessels and lymph sac J:239583
Tg(CAG-Bgeo,-Hras1,-EGFP)#Ichi/0
Tg(Flt4-cre)44Ichi/0
(involves: 129P2/OlaHsd * C57BL/6J) 		lymphatic vessel hyperplasia J:159024
Tg(CAG-Bgeo,-Hras1,-EGFP)#Ichi/0
Tg(Tek-cre)12Flv/0
(involves: 129P2/OlaHsd * C3H * C57BL/6) 		lymphatic vessel hyperplasia J:159024
Tg(CAG-Has2)99Nita/0
Tg(MMTV-cre)4Mam/0
Tg(MMTVneu)202Mul/0
(FVB.Cg-Tg(CAG-Has2)99Nita Tg(MMTV-cre)4Mam Tg(MMTVneu)202Mul) 		abnormal lymphatic vessel morphology J:130531
Tg(CAG-Has2)99Nita/0
Tg(MMTVneu)202Mul/0
(FVB.Cg-Tg(CAG-Has2)99Nita Tg(MMTVneu)202Mul) 		abnormal lymphatic vessel morphology J:130531
Tg(KRT14-FIGF)2Ali/0
(involves: FVB/N) 		lymphatic vessel hyperplasia J:137909, J:68138
Tg(KRT14-FLT4/IGHG1)#Ali/0
(either: (involves: FVB/N) or (involves: BALB/c * DBA)) 		abnormal lymphatic vessel morphology J:201429
Tg(KRT14-Vegfa)3Dtm/0
(FVB/N-Tg(KRT14-Vegfa)3Dtm) 		abnormal lymphatic vessel morphology J:111924
enlarged lymphatic vessel J:92643
Tg(KRT14-VEGFC*)1Ali/0
(involves: FVB/N) 		lymphatic vessel hyperplasia J:68138
Tg(KRT14-Vegfd)1Ali/0
Vegfctm1Ali/Vegfc+
(involves: 129S1/Sv * 129X1/SvJ * FVB) 		abnormal lymphatic vessel morphology J:137909
Tg(Prox1-EGFP)KY221Gsat/0
(involves: FVB/NTac) 		abnormal lymphangiogenesis J:235778
abnormal lymphatic vessel endothelial cell morphology J:235778
Tie1tm1.1Scba/Tie1tm1.1Scba
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N) 		abnormal lymphangiogenesis J:158668
abnormal lymphatic vessel morphology J:158668
lymphatic vessel hyperplasia J:158668
Tie1tm1Geno/Tie1tm1Geno
(involves: ICR) 		abnormal lymphangiogenesis J:159507
Tie1tm1Jpa/Tie1tm1Jpa
(involves: 129S1/Sv * 129X1/SvJ * ICR) 		abnormal lymphangiogenesis J:159507
Tie1tm1Scba/Tie1tm1Scba
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal lymphangiogenesis J:158668
abnormal lymphatic vessel morphology J:158668
lymphatic vessel hyperplasia J:158668
Tmem204tm1.1Ali/Tmem204tm1.1Ali
(involves: BALB/c * C57BL/6) 		abnormal lymphatic vessel smooth muscle morphology J:159519
enlarged lymphatic vessel J:159519
Tmem204tm1Ali/Tmem204tm1Ali
Tg(Tie1-cre)9Ref/0
(involves: 129S1/Sv * 129X1/SvJ) 		enlarged lymphatic vessel J:159519
Tulp4tm1a(KOMP)Wtsi/Tulp4+
(involves: C57BL/6N * C57BL/6NRj) 		absent connection between subcutaneous lymph vessels and lymph sac J:344151
Ube3bGt(RRJ142)Byg/Ube3bGt(RRJ142)Byg
(involves: 129P2/OlaHsd * CBA/Ca) 		lymphangiectasis J:203652
Vegfatm1.1Nagy/Vegfatm1.1Nagy
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal lymphatic vessel morphology J:64090
Vegfctm1Ali/Vegfc+
(involves: 129S1/Sv * 129X1/SvJ * ICR) 		lymphatic vessel hypoplasia J:87394
Vegfctm1Ali/Vegfc+
(involves: 129S1/Sv * 129X1/SvJ) 		lymphatic vessel hypoplasia J:137909
Vegfctm1Ali/Vegfc+
Tg(KRT14-FIGF)2Ali/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/N) 		lymphatic vessel hyperplasia J:137909
Vegfctm1Ali/Vegfctm1Ali
(involves: 129S1/Sv * 129X1/SvJ * ICR) 		absent lymphatic vessels J:87394
Vegfctm1Ali/Vegfctm1Ali
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal lymphangiogenesis J:137909
abnormal lymphatic vessel morphology J:137909
Vegfdtm1Mach/Vegfdtm1Mach
Vegfctm1Ali/Vegfctm1Ali
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal lymphangiogenesis J:137909
abnormal lymphatic vessel morphology J:137909
Vezf1tm1Stmn/Vezf1+
(B6.129-Vezf1tm1Stmn) 		abnormal lymphatic vessel morphology J:99326
Zbtb46tm2.1Mnz/Zbtb46tm2.1Mnz
(involves: C57BL/6) 		abnormal lymphangiogenesis J:191314
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
04/16/2024
MGI 6.23 		The Jackson Laboratory